Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1068 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

SurModics revenue falls in Q3

SurModics‘ net income was $3.84m, compared to net loss of $916,000 for the same period in the prior year. The company’s income from operations was $3.45m for the

FDA approves new treatment for scorpion sting

Manufactured by Instituto Bioclon, Anascorp, Centruroides (Scorpion) Immune F(ab’)2 (Equine) Injection, is made from the plasma of horses immunized with scorpion venom. The FDA approval is based on

BioClinica Q2 revenues rise

BioClinica‘s net income was $924,000, compared to $403,000 for the same period in the prior year. The company’s income from operations were $1.48m for the second quarter ended